RecallRadar

FDA Device recall Z-1424-2022

Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma

On 2022-07-27 the FDA classified a Class II recall of Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma by Randox Laboratories, citing product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-1424-2022
ClassificationClass II
Statusterminated
Initiated2022-06-22
Published2022-07-27
Last updated2026-09-13 11:56 UTC
CompanyRandox Laboratories
DistributionUS

Product

Randox Cholesterol- For the quantitative in vitro determination of Cholesterol in serum and plasma. Catalog Number: CH2O0

Reason

Product fails to meet the performance claims quoted on the kit insert: Manual Procedure when calibrating using the standard provided in the kit, the change in absorbance is lower than expected generating internal quality control results high outside range; Cholesterol (CHOL) Instrument Specific Application using the recommended calibration material CAL2351, the product fails to meet its linearity performance claim quoted on the kit inserts. The linearity is reduced by up to -35% however Quality Control results will still fall within assigned ranges. This may lead to delayed results.

Identifiers

code_infoGTIN : 05055273201130 Lot Number: 586177 Expiry Date: 28th Jan 2024

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1424-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.